A trial looking at ceralasertib for ovarian and endometrial clear cell cancers (ATARI)

This trial is for people with certain subtypes of gynaecological cancers that have come back after treatment. It is open to people with ovarian or endometrial clear cell cancers and certain types of other rare gynaecological cancers particularly endometrioid, carcinosarcoma or cervical cancers.

You pronounce ceralasertib as se-ra-la-sir-tib.

Cancer Research UK supports this trial.